Dr. Safa Arfeen is a Royal Oak, Michigan based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Safa Arfeen is 4351046633 for Ophthalmology in Michigan. Dr. Safa Arfeen is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Safa Arfeen speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Female
Practice Address:
3601 W 13 Mile Rd Ofc, Royal Oak, Michigan, 48073-6712
Phone:
248-551-6347
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1154944437
NPI Enumeration Date:
21 May, 2020
NPI Last Update On:
21 May, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Safa Arfeen are as mentioned below.
License Number
Specialization
State
Status
4351046633
Ophthalmology
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3601 W 13 Mile Rd Ofc, Royal Oak, Michigan
Zip:
48073-6712
Phone Number:
248-551-6347
Fax Number:
--
Patients can reach Dr. Safa Arfeen at 3601 W 13 Mile Rd Ofc, Royal Oak, Michigan or can call to book an appointment on 248-551-6347. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.